🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 5-year project, involving 185 partners from 46 countries ((110 in...
Status
Completed
Location
Istituto Giannina Gaslini
Start Date
2006-05-31
Trial ID
NCT00323960
Treatments Being Tested
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This study will evaluate the efficacy, safety and patient reported outcomes...
Status
Unknown
Location
Multiple Locations
Start Date
2020-09-01
Trial ID
NCT04516655
Treatments Being Tested
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This prospective, within subject clinical trial aims to evaluate the effica...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-01
Trial ID
NCT06877455
Treatments Being Tested
Objectives: A. Primary objective: 1 To assess the feasibility and the eff...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09-12
Trial ID
NCT00866749
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
This is a phase II open label trial designed to evaluate the efficacy of Ta...
Status
Completed
Location
Froedtert Hospital and the Medical College of Wisconsin
Start Date
2014-12
Trial ID
NCT02206035
Treatments Being Tested
This randomized clinical trial studies standard GVHD prophylaxis with tacro...
Status
Completed
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2014-07-07
Trial ID
NCT01951885
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229